HomeOGN • NYSE
add
Organon & Co
Previous close
$7.14
Day range
$7.04 - $7.19
Year range
$6.18 - $17.23
Market cap
1.86B USD
Avg Volume
7.75M
P/E ratio
3.71
Dividend yield
1.12%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.60B | 1.26% |
Operating expense | 499.00M | -6.38% |
Net income | 160.00M | -55.43% |
Net profit margin | 9.99 | -55.97% |
Earnings per share | 1.01 | 16.09% |
EBITDA | 462.00M | 0.65% |
Effective tax rate | 34.16% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 672.00M | -11.93% |
Total assets | 13.55B | 6.27% |
Total liabilities | 12.65B | 3.16% |
Total equity | 906.00M | — |
Shares outstanding | 259.98M | — |
Price to book | 2.05 | — |
Return on assets | 6.84% | — |
Return on capital | 9.55% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 160.00M | -55.43% |
Cash from operations | 264.00M | 87.23% |
Cash from investing | -115.00M | -53.33% |
Cash from financing | -76.00M | 2.56% |
Net change in cash | 73.00M | 23.73% |
Free cash flow | 96.25M | 231.90% |
About
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
Founded
1923
Headquarters
Website
Employees
10,000
